(Q38552975)

English

Standardization of pathologic evaluation and reporting of postneoadjuvant specimens in clinical trials of breast cancer: recommendations from an international working group

scientific article published on 24 July 2015

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 September 2017

Standardization of pathologic evaluation and reporting of postneoadjuvant specimens in clinical trials of breast cancer: recommendations from an international working group (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 September 2017

1 reference

based on heuristic

inferred from title

Frédérique Penault-Llorca

8

object named as

Frédérique Penault-Llorca

0 references

Gaëtan MacGrogan

7

object named as

Gaëtan MacGrogan

1 reference

Europe PubMed Central

PubMed publication ID

4 September 2017

Carsten Denkert

object named as

Carsten Denkert

6

0 references

Giuseppe Curigliano

object named as

Giuseppe Curigliano

10

0 references

3

object named as

Giuseppe Viale

1 reference

Europe PubMed Central

PubMed publication ID

4 September 2017

9

object named as

Judy Boughey

1 reference

Europe PubMed Central

PubMed publication ID

4 September 2017

author name string

Elena Provenzano

1

1 reference

Europe PubMed Central

PubMed publication ID

4 September 2017

Veerle Bossuyt

2

1 reference

Europe PubMed Central

PubMed publication ID

4 September 2017

David Cameron

4

1 reference

Europe PubMed Central

PubMed publication ID

4 September 2017

Sunil Badve

5

1 reference

Europe PubMed Central

PubMed publication ID

4 September 2017

J Michael Dixon

11

1 reference

Europe PubMed Central

PubMed publication ID

4 September 2017

Laura Esserman

12

1 reference

Europe PubMed Central

PubMed publication ID

4 September 2017

Gerd Fastner

13

1 reference

Europe PubMed Central

PubMed publication ID

4 September 2017

Thorsten Kuehn

14

1 reference

Europe PubMed Central

PubMed publication ID

4 September 2017

Florentia Peintinger

15

1 reference

Europe PubMed Central

PubMed publication ID

4 September 2017

Gunter von Minckwitz

16

1 reference

Europe PubMed Central

PubMed publication ID

4 September 2017

Julia White

17

1 reference

Europe PubMed Central

PubMed publication ID

4 September 2017

Wei Yang

18

1 reference

Europe PubMed Central

PubMed publication ID

4 September 2017

W Fraser Symmans

19

1 reference

Europe PubMed Central

PubMed publication ID

4 September 2017

Residual Disease Characterization Working Group of the Breast International Group-North American Breast Cancer Group Collaboration

20

1 reference

Europe PubMed Central

PubMed publication ID

4 September 2017

publication date

24 July 2015

1 reference

Europe PubMed Central

PubMed publication ID

4 September 2017

number of pages

17

1 reference

based on heuristic

inferred from page(s)

Modern Pathology

1 reference

Europe PubMed Central

PubMed publication ID

4 September 2017

28

1 reference

Europe PubMed Central

PubMed publication ID

4 September 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

4 September 2017

1185-1201

1 reference

Europe PubMed Central

PubMed publication ID

4 September 2017

Axillary lymph node scarring and the association with tumour response following neoadjuvant chemoendocrine therapy for breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/26205180

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/26205180

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Loss of HER2 amplification following trastuzumab-based neoadjuvant systemic therapy and survival outcomes

1 reference

https://pubmed.ncbi.nlm.nih.gov/26205180

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ki67 measured after neoadjuvant chemotherapy for primary breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/26205180

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Value of Combined Large Format Histopathology Technique to Assess the Surgically Removed Breast Tissue following Neoadjuvant Chemotherapy: A Single Institution Study of 40 Cases

1 reference

https://pubmed.ncbi.nlm.nih.gov/26205180

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Incidence and prognostic significance of complete axillary downstaging after primary chemotherapy in breast cancer patients with T1 to T3 tumors and cytologically proven axillary metastatic lymph nodes

1 reference

https://pubmed.ncbi.nlm.nih.gov/26205180

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recommendations for collection and handling of specimens from group breast cancer clinical trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/26205180

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

American Joint Committee on Cancer tumor-node-metastasis stage after neoadjuvant chemotherapy and breast cancer outcome

1 reference

https://pubmed.ncbi.nlm.nih.gov/26205180

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A central review of histopathology reports after breast cancer neoadjuvant chemotherapy in the neo-tango trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/26205180

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Measurement of residual breast cancer burden to predict survival after neoadjuvant chemotherapy.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26205180

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized parallel study of doxorubicin plus paclitaxel and doxorubicin plus cyclophosphamide as neoadjuvant treatment of patients with breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/26205180

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Change in the hormone receptor status following administration of neoadjuvant chemotherapy and its impact on the long-term outcome in patients with primary breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/26205180

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Residual proliferative cancer burden to predict long-term outcome following neoadjuvant chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/26205180

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pathology of breast carcinomas after neoadjuvant chemotherapy: an overview with recommendations on specimen processing and reporting

1 reference

https://pubmed.ncbi.nlm.nih.gov/26205180

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Accelerating identification and regulatory approval of investigational cancer drugs

1 reference

https://pubmed.ncbi.nlm.nih.gov/26205180

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pathobiology of preoperative chemotherapy: findings from the National Surgical Adjuvant Breast and Bowel (NSABP) protocol B-18

1 reference

https://pubmed.ncbi.nlm.nih.gov/26205180

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Validation of a novel staging system for disease-specific survival in patients with breast cancer treated with neoadjuvant chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/26205180

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Responsiveness of adjacent ductal carcinoma in situ and changes in HER2 status after neoadjuvant chemotherapy/trastuzumab treatment in early breast cancer--results from the GeparQuattro study (GBG 40)

1 reference

https://pubmed.ncbi.nlm.nih.gov/26205180

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A new histological grading system to assess response of breast cancers to primary chemotherapy: prognostic significance and survival

1 reference

https://pubmed.ncbi.nlm.nih.gov/26205180

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic value of a positive-to-negative change in hormone receptor status after neoadjuvant chemotherapy in patients with hormone receptor-positive breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/26205180

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Change in HER2 (ERBB2) gene status after taxane-based chemotherapy for breast cancer: polyploidization can lead to diagnostic pitfalls with potential impact for clinical management.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26205180

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A new prognostic classification after primary chemotherapy for breast cancer: residual disease in breast and nodes (RDBN)

1 reference

https://pubmed.ncbi.nlm.nih.gov/26205180

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Variability in hormone and growth factor receptor expression in primary versus recurrent, metastatic, and post-neoadjuvant breast carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/26205180

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Assessment of Ki67 in breast cancer: recommendations from the International Ki67 in Breast Cancer working group

1 reference

https://pubmed.ncbi.nlm.nih.gov/26205180

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Pathologic Complete Response Open Question in Primary Therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/26205180

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Change in tumor cellularity of breast carcinoma after neoadjuvant chemotherapy as a variable in the pathologic assessment of response

1 reference

https://pubmed.ncbi.nlm.nih.gov/26205180

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic significance of occult axillary lymph node metastases after chemotherapy-induced pathologic complete response of cytologically proven axillary lymph node metastases from breast cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26205180

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/26205180

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reproducibility of residual cancer burden for prognostic assessment of breast cancer after neoadjuvant chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/26205180

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Is Nottingham prognostic index useful after induction chemotherapy in operable breast cancer?

1 reference

https://pubmed.ncbi.nlm.nih.gov/26205180

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/26205180

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A novel automated assay for the rapid identification of metastatic breast carcinoma in sentinel lymph nodes

1 reference

https://pubmed.ncbi.nlm.nih.gov/26205180

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An international Ki67 reproducibility study

1 reference

https://pubmed.ncbi.nlm.nih.gov/26205180

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic role of the extent of peritumoral vascular invasion in operable breast cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26205180

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Predictors of locoregional recurrence after neoadjuvant chemotherapy: results from combined analysis of National Surgical Adjuvant Breast and Bowel Project B-18 and B-27.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26205180

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pure and predominantly pure intralymphatic breast carcinoma after neoadjuvant chemotherapy: an unusual and adverse pattern of residual disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/26205180

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Changes in and prognostic value of hormone receptor status in a series of operable breast cancer patients treated with neoadjuvant chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/26205180

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pathologic response to induction chemotherapy in locally advanced carcinoma of the breast: a determinant of outcome

1 reference

https://pubmed.ncbi.nlm.nih.gov/26205180

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Laboratory handling and histology reporting of breast specimens from patients who have received neoadjuvant chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/26205180

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Number of lymph nodes identified at axillary dissection: effect of neoadjuvant chemotherapy and other factors

1 reference

https://pubmed.ncbi.nlm.nih.gov/26205180

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of the prognostic significance of Chevallier and Sataloff's pathologic classifications after neoadjuvant chemotherapy of operable breast cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26205180

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Histologic regression of breast cancer after primary (neoadjuvant) chemotherapy]

1 reference

https://pubmed.ncbi.nlm.nih.gov/26205180

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Residual ductal carcinoma in situ in patients with complete eradication of invasive breast cancer after neoadjuvant chemotherapy does not adversely affect patient outcome

1 reference

https://pubmed.ncbi.nlm.nih.gov/26205180

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Size of residual lymph node metastasis after neoadjuvant chemotherapy in locally advanced breast cancer patients is prognostic

1 reference

https://pubmed.ncbi.nlm.nih.gov/26205180

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Correlation between response to neoadjuvant chemotherapy and survival in locally advanced breast cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/26205180

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The hormonal receptor status in breast cancer can be altered by neoadjuvant chemotherapy: a meta-analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/26205180

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Definition and impact of pathologic complete response on prognosis after neoadjuvant chemotherapy in various intrinsic breast cancer subtypes.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26205180

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Predictors of local-regional recurrence after neoadjuvant chemotherapy and mastectomy without radiation

1 reference

https://pubmed.ncbi.nlm.nih.gov/26205180

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Outcome after pathologic complete eradication of cytologically proven breast cancer axillary node metastases following primary chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/26205180

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The prognostic significance of Ki67 before and after neoadjuvant chemotherapy in breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/26205180

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Histopathologic evidence of tumor regression in the axillary lymph nodes of patients treated with preoperative chemotherapy correlates with breast cancer outcome

1 reference

https://pubmed.ncbi.nlm.nih.gov/26205180

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Outcome prediction for estrogen receptor-positive breast cancer based on postneoadjuvant endocrine therapy tumor characteristics

1 reference

https://pubmed.ncbi.nlm.nih.gov/26205180

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recommendations for standardized pathological characterization of residual disease for neoadjuvant clinical trials of breast cancer by the BIG-NABCG collaboration

1 reference

https://pubmed.ncbi.nlm.nih.gov/26205180

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Changes and predictive and prognostic value of the mitotic index, Ki-67, cyclin D1, and cyclo-oxygenase-2 in 710 operable breast cancer patients treated with neoadjuvant chemotherapy.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26205180

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inflammatory breast cancer. Pilot study of intensive induction chemotherapy (FEC-HD) results in a high histologic response rate.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26205180

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neoadjuvant chemotherapy in invasive breast cancer results in a lower axillary lymph node count

1 reference

https://pubmed.ncbi.nlm.nih.gov/26205180

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preoperative chemotherapy: updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26205180

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Issues in the assessment of the pathologic effect of primary systemic therapy for breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/26205180

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pathologic response and long-term follow-up in breast cancer patients treated with neoadjuvant chemotherapy: a comparison between classifications and their practical application

1 reference

https://pubmed.ncbi.nlm.nih.gov/26205180

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study

1 reference

https://pubmed.ncbi.nlm.nih.gov/26205180

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

How do we measure a residual tumor size in histopathology (the gold standard) after neoadjuvant chemotherapy?

1 reference

https://pubmed.ncbi.nlm.nih.gov/26205180

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Proposals for uniform collection of biospecimens from neoadjuvant breast cancer clinical trials: timing and specimen types.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26205180

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The prognostic significance of lymph node metastases after preoperative chemotherapy for locally advanced breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/26205180

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Axillary lymph node count is lower after neoadjuvant chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/26205180

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mitotic counts in breast cancer after neoadjuvant systemic chemotherapy and development of metastatic disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/26205180

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Typing breast cancer following primary chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/26205180

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/MODPATHOL.2015.74

1 reference

Europe PubMed Central

PubMed publication ID

4 September 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38552975&oldid=2201821037"